Shalby
add_icon

Shalby

138.79
-5.80
(-4.01%)
Market Cap
1,499.07 Cr
PE Ratio
392.30
Volume
98,259.00
Day High - Low
143.00 - 137.82
52W High-Low
274.70 - 138.43
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
1,499.07 Cr
EPS
0.18
PE Ratio
392.30
PB Ratio
1.56
Book Value
92.82
EBITDA
160.20
Dividend Yield
0.00 %
Sector
Hospitals
Return on Equity
0.19
Debt to Equity
0.43
Analyst Rating and Forecast
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
Shalby Limited launches advanced oncology department with radiotherapy facilities at its Surat hospital, providing comprehensive cancer treatment services under one roof.
positive
PK Healthcare Private Limited, a subsidiary of Shalby Limited operating as Shalby International Hospitals in Gurugram, has received NABH accreditation under 6th Edition Standards, valid until 2030.
negative
Shalby has discontinued its SOCE (Surgery on Correct site and Correct patient Every time) activities in Rajkot and Lucknow facilities citing economic unworkability as the primary reason for this operational decision.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
7,252.00
#1 1,04,272.63
57.56
#1 21,994.30
14.76
#1 1,505
36.08
34.26
953.10
92,714.65
67.18
7,184.10
#1 28.65
1,076
26.01
28.00
818.35
61,782.00
65.10
7,849.70
13.25
809
-22.38
36.01
1,648.30
33,684.79
44.32
5,575.00
12.29
790
-34.33
35.01
636.20
32,962.86
95.49
4,286.70
15.12
337
-8.85
48.10
1,014.60
27,271.47
54.75
3,771.40
12.59
481
-33.52
29.28
657.55
26,311.14
85.50
3,067.00
21.98
415
-43.89
44.95
423.50
13,402.50
85.52
1,757.00
27.64
110
#1 54.61
36.69
5,249.40
11,810.82
#1 24.58
599.90
11.69
58
12.46
48.60
1,103.80
11,210.10
43.91
1,566.90
17.46
244
7.26
32.14
Growth Rate
Revenue Growth
16.93 %
Net Income Growth
-97.72 %
Cash Flow Change
-122.14 %
ROE
-97.71 %
ROCE
-32.59 %
EBITDA Margin (Avg.)
-30.28 %

Quarterly Financial Results

Quarterly Financials
Jun 2017
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
91
119
122
115
116
133
128
123
119
41
118
134
147
195
184
165
167
206
207
207
208
240
243
221
249
289
275
281
270
303
290
279
Expenses
64
91
97
93
98
102
98
99
106
43
86
101
114
154
152
139
139
162
165
169
173
192
185
174
205
234
235
242
244
255
244
242
EBITDA
27
27
25
22
17
31
30
24
13
-3
32
33
33
41
32
27
28
44
42
38
35
48
58
47
44
55
40
39
26
49
46
38
Operating Profit %
29 %
21 %
19 %
17 %
13 %
22 %
22 %
18 %
2 %
-13 %
26 %
23 %
21 %
20 %
16 %
15 %
15 %
20 %
18 %
17 %
13 %
18 %
22 %
20 %
16 %
16 %
12 %
12 %
8 %
14 %
15 %
11 %
Depreciation
4
8
8
9
8
9
9
9
9
9
9
9
9
9
12
11
11
12
12
12
13
12
12
12
16
16
17
16
16
17
17
18
Interest
4
2
2
2
3
1
1
2
2
1
1
1
1
1
2
2
2
2
2
3
3
3
3
4
7
8
9
11
11
9
10
11
Profit Before Tax
19
18
15
12
7
21
20
14
2
-13
22
23
23
31
19
14
15
31
29
24
19
33
43
31
22
30
14
12
-1
23
19
9
Tax
4
6
11
-2
4
-3
7
6
19
-4
-3
6
13
11
8
1
5
11
10
8
5
12
15
12
6
16
11
15
11
15
12
8
Net Profit
15
12
4
13
3
24
13
8
-17
-9
25
17
10
20
11
13
10
20
18
15
14
21
28
19
16
15
2
-3
-12
8
7
1
EPS in ₹
1.63
1.11
0.33
1.24
0.30
2.19
1.20
0.75
-1.58
-0.81
2.27
1.56
0.91
1.87
0.99
1.20
0.94
1.87
1.71
1.42
1.29
1.94
2.57
1.78
1.49
1.37
0.22
-0.28
-1.13
0.71
0.68
0.12

Balance Sheet

Balance Sheet
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
679
961
939
967
997
1,194
1,281
1,608
1,704
Fixed Assets
323
650
692
673
660
675
685
966
955
Current Assets
89
212
197
234
271
449
517
552
658
Capital Work in Progress
221
47
3
6
8
6
11
15
22
Investments
0
0
11
28
16
25
146
81
95
Other Assets
135
264
233
260
314
488
440
545
632
Total Equity & Liabilities
679
961
939
967
997
1,194
1,281
1,608
1,704
Current Liabilities
130
115
88
83
82
173
194
323
455
Non Current Liabilities
298
95
71
84
80
145
159
277
253
Total Equity
251
752
780
799
835
876
928
1,008
995
Reserve & Surplus
164
643
672
691
727
768
820
893
885
Share Capital
87
108
108
108
108
108
107
107
108

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
22
-19
3
0
-6
3
-2
49
-43
15
8
Investing Activities
-62
-98
-153
-236
1
-31
-51
-60
-61
146
-36
Operating Activities
123
5
61
14
43
55
79
19
68
20
-4
Financing Activities
-39
75
96
222
-51
-22
-30
91
-50
-151
48

Share Holding

% Holding
Mar 2021
May 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
79.45 %
74.07 %
74.07 %
74.02 %
74.02 %
74.02 %
74.04 %
74.04 %
74.12 %
74.12 %
74.12 %
74.12 %
74.12 %
74.24 %
74.25 %
74.25 %
74.27 %
74.27 %
74.27 %
74.33 %
74.33 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
4.11 %
4.62 %
4.88 %
5.35 %
5.37 %
4.65 %
4.54 %
5.20 %
4.64 %
4.47 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.06 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.06 %
0.09 %
0.14 %
0.18 %
0.20 %
0.20 %
0.20 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
11.68 %
11.97 %
11.14 %
11.16 %
12.03 %
11.86 %
11.91 %
11.95 %
11.06 %
11.13 %
11.28 %
11.35 %
10.66 %
10.40 %
9.97 %
10.09 %
10.78 %
10.67 %
11.20 %
11.74 %
11.73 %
Others
8.86 %
13.96 %
14.79 %
14.82 %
13.95 %
14.13 %
14.06 %
14.01 %
14.76 %
14.75 %
14.59 %
10.42 %
10.60 %
10.49 %
10.37 %
10.20 %
10.16 %
10.34 %
9.13 %
9.11 %
9.29 %
No of Share Holders
55,974
54,939
52,524
53,854
55,562
55,233
54,666
54,537
52,775
52,181
52,580
50,225
49,495
49,858
49,315
51,479
52,328
52,895
53,437
53,784
52,495

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.5 0.5 1 1 1.2 1.2 0.00 0.00
Dividend Yield (%) 0.00 0.00 1.08 0.5 0.85 0.77 0.5 0.61 0.00 0.00

Announcements

Disclosure Under Reg. 30 Of SEBI (LODR) Regulations 2015 - Major Development - Inauguration Of Oncology Department Along With Advanced Radiotherapy Facilities At Shalby Hospital Surat10 days ago
NABH Accreditation To PK Healthcare Pvt Ltd. (Shalby International Hospitals) - Subsidiary CompanyMar 03, 2026
Credit Of Equity Shares By Subsidiary Company On Rights Issue Basis To The CompanyFeb 28, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 18, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 18, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 17, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 12, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 11, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 11, 2026
Closure Of Step-Down SubsidiaryFeb 11, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 11, 2026
Board Meeting Outcome for Unaudited Standalone And Consolidated Financial Results For Quarter Ended December 31 2025.Feb 11, 2026
Intimation For Availing Of Working Capital FacilitiesFeb 06, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 02, 2026
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Period Ended December 31 2025 And Other Business MattersFeb 02, 2026
Update On SOCE Rajkot And LucknowJan 31, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 20, 2026
Monthly Report On Re-Lodgement For Transfer Requests Of Physical Shares For The Month December 2025Jan 06, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 31, 2025
Closure of Trading WindowDec 27, 2025
Monthly Report On Re-Lodgement For Transfer Requests Of Physical Shares For The Month November 2025Dec 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 20, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 15, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2025
Grant Of 19000 Employee Stock OptionsNov 13, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 13, 2025
Disclosure Under Reg. 30(5) For Determining Materiality Of An Event Or Information And To Make Disclosure To Stock ExchangesNov 13, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementNov 13, 2025
Board Meeting Outcome for Outcome Of Board MeetingNov 13, 2025
Exercise Of 2000 Esops By Eligible EmployeeNov 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2025
Issuance Of Corporate Guarantee For Fund And Non-Fund Based Credit Facilities Granted To PK Healthcare Private Limited (Subsidiary Company)Nov 07, 2025
Monthly Report On Re-Lodgement For Transfer Requests Of Physical Shares For The Month October 2025Nov 07, 2025
Board Meeting Intimation for Unaudited Results Of Quarter And Half Year Ended September 30 2025.Nov 05, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 29, 2025
Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special WindowOct 25, 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Oct 24, 2025
ESG Ratings Assigned By Crisil ESG Ratings & AnalyticsOct 17, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 06, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 30, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 29, 2025
Closure of Trading WindowSep 25, 2025
Disclosure Under Regulation 29(2) Of Securities Exchange Board Of India (Substantial Acquisition Of Shares And Takeover) Regulations 2011Sep 20, 2025
Disclosure Under Regulation 7(2) Of Securities Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015Sep 20, 2025
Special Window For Re-Lodgement Of Transfer Requests Of Physical SharesSep 19, 2025
Dispatch Of Letters To Shareholders Sharing The Web-Link Of Annual Report FY 2024-25 - Reg. 36(1)(B) Of SEBI LODRSep 09, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 08, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.03%
0
0.00%
-0.01%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
39.22
ATR(14)
Less Volatile
6.10
STOCH(9,6)
Neutral
22.51
STOCH RSI(14)
Neutral
34.91
MACD(12,26)
Bullish
0.11
ADX(14)
Strong Trend
25.46
UO(9)
Bearish
40.14
ROC(12)
Downtrend But Slowing Down
-6.61
WillR(14)
Neutral
-70.54